This development also made Monarch the first minimally invasive RAS platform for medical procedures on lungs and bronchus to be officially licensed in China.
Trending posts in the last week
Prefecture-level city under Hangzhou earmarks US$700m to build ‘robot town’
Shandong maps out path to US$1.4b in drone industry output by 2025
Movers and shakers: Who raised funds in November 2023 and who are they?
Unmanned chopper builder FlightWin bags US$14m in Series B+ raise